Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)

Clinical trial NCT02708186 · COMPLETED

Trial details

NCT number: NCT02708186
Sponsor: Axovant Sciences Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dementia With Lewy Bodies REM Sleep Behavior Disorder Parkinson's Disease Dementia

Start date: 2016-03-01
Primary completion: 2018-05-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.